Acute Graft Versus Host Disease: A Clinical Compendium on Answers to Clinicians’ Questions in Prevention and Management

To participate in this activity, please:

Bone marrow transplant specialist Nelson Chao, MD, dives into the topic of acute graft-versus-host disease (aGVHD), the most common complication after hematopoietic stem cell transplant (HSCT). Discussion surrounds the classification, diagnosis, severity, grading, and staging of aGVHD. He discusses recent guideline updates and recommended clinical management strategies for the prevention and treatment of patients with aGVHD and provides his insight into the current and emerging therapies undergoing evaluation in late-phase clinical trials. Finally, Dr. Chao highlights the burden of disease for patients, identifies patient resources and supportive measures, and provides his clinical perspective on the future management of patients with aGVHD.

Course Credit:

1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
1 CA-BRN Contact Hour
0.5 Pharmacology Hours


Opens: 2023-03-27
Closes: 2024-03-27

Target Audience:

This activity was developed for hematologists, oncologists, physician assistants, nurse practitioners, nurses and all other healthcare professionals involved in the care of patients with graft-versus-host disease.

This activity is supported by an educational grant from CSL Behring.

    Presenting Faculty

  • Nelson Chao, MD, MBA

    Donald D. and Elizabeth G. Cooke Professor
    Chief, Division of Hematologic Malignancies and Cellular Therapy/BMT
    Director, Duke Global Health Institute
    Duke University
    Durham, North Carolina